<DOC>
	<DOC>NCT02390297</DOC>
	<brief_summary>Long term safety follow-up of Cal-1 recipients</brief_summary>
	<brief_title>Long Term Follow up for the Detection of Delayed Adverse Events in Cal-1 Recipients</brief_title>
	<detailed_description>Long Term Follow-up for the Detection of Delayed Adverse Events in Recipients of CD4+ T Lymphocytes and/or CD34+ Hematopoietic Stem/Progenitor Cells Transduced with LVsh5/C46 (Cal-1), a Dual Anti-HIV Gene Transfer Construct</detailed_description>
	<criteria>Signed informed consent Previous treatment with the Cal1 modified hematopoietic cellular products Inability to understand and provide informed consent</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2016</verification_date>
</DOC>